have people died from semaglutide reduces risk of all-cause death The black market for weight-loss

Abstract Alzheimers disease (AD) accounts for two-thirds of all dementia cases, affecting 50 million people worldwide

Your Dose May Need Adjustment Some individuals require a higher therapeutic dose before experiencing consistent appetite suppression

Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone your body naturally produces after eating

For women needing stronger support, our Nurse Practitioner provides BHRTBioidentical Estrogen, Progesterone, Testosterone, and DHEA creams, gels, and troches, safely prescribed and monitored in-house

No human trials as of June 2026

For medical advice, an in-person or telemedicine consultation is required